[Histopathology of neuroendocrine tumors]. 1997

J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
Laboratoire d'Anatomie Pathologique CHU, Angers.

Neuroendocrine (NE) tumors are a heterogeneous group of neoplasms arising in various organs and sharing the features of the NE cell system. The term "neuroendocrine" is used for cells characterized by their secretory products and some cytoplasmic proteins rather than by their localization and embryological derivation. Some tumor types can show a characteristic pattern on conventional histology but, to obtain an accurate diagnosis of many NE tumors it is necessary to employ various special methods, mainly electron microscopy and immuno-histochemistry. The classification of NE tumors in four categories according to Travis et al. is largely used: typical carcinoid and atypical carcinoid are low grade neoplasms; small cell NE carcinoma and large cell NE carcinoma are high grade neoplasms. The size, extension into surrounding tissues, angioinvasion and hormonal function are also important to consider in the prognostic evaluation of some NE tumors. Tumors exhibiting multidirectional differentiation must be classified in carcinoma with interspersed NE cells, carcinoid with interspersed non NE cells, composite tumors and amphricine tumors. Finally, some NE tumors may present features suggesting a Multiple Endocrine Neoplasia, ie. multifocality and association with hyperplasia of endocrine cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018358 Neuroendocrine Tumors Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition. Neuroendocrine Tumor,Tumor, Neuroendocrine,Tumors, Neuroendocrine

Related Publications

J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
July 2002, Current opinion in pulmonary medicine,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
January 2019, Acta cytologica,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
January 2013, Frontiers in oncology,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
September 2021, Endocrine pathology,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
March 2004, Applied immunohistochemistry & molecular morphology : AIMM,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
January 1972, Bulletin du cancer,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
October 2022, Dermatologic clinics,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
November 2020, American journal of clinical pathology,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
April 1988, Nederlands tijdschrift voor tandheelkunde,
J P Saint-André, and F Dupré, and F Chenue, and S Guyétant
March 2007, Best practice & research. Clinical endocrinology & metabolism,
Copied contents to your clipboard!